PREVENtion of HeartMate II Pump Thrombosis

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

June 30, 2016

Conditions
HeartMate II Pump Thrombosis
Interventions
OTHER

Clinical Management Recommendations for reducing pump thrombosis

Clinical Management Recommendations for reducing pump thrombosis

Trial Locations (23)

15212

Allegheny General Hospital, Pittsburgh

15213

University of Pittsburgh Medical Center, Pittsburgh

19001

Abington Memorial Hospital, Abington

19107

Thomas Jefferson University Hospital, Philadelphia

22042

Inova Fairfax Hospital, Falls Church

27599

University of North Carolina, Chapel Hill

32610

Shands Hospital at University of Florida, Gainesville

37232

Vanderbilt University Medical Center, Nashville

40202

Jewish Hospital, Louisville

43210

Ohio State University, Columbus

45219

The Christ Hospital, Cincinnati

55407

Abbott Northwestern, Minneapolis

55455

University of Minnesota Medical Center, Minneapolis

55905

Mayo Clinic, St. Mary's, Rochester

60611

Northwestern Memorial, Chicago

60637

University of Chicago, Chicago

72205

Baptist Medical Center, Little Rock

77030

Memorial Hermann/UT Texas, Houston

80045

University of Colorado, Aurora

90095

UCLA Medical Center, Los Angeles

92037

University of California, San Diego, La Jolla

92123

Sharp Memorial Hospital, San Diego

95819

Sutter Memorial, Sacramento

Sponsors
All Listed Sponsors
collaborator

Thoratec Corporation

INDUSTRY

lead

Abbott Medical Devices

INDUSTRY

NCT02158403 - PREVENtion of HeartMate II Pump Thrombosis | Biotech Hunter | Biotech Hunter